| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care
|
Parker, Ann M
|
|
|
9 |
11 |
p. 1328-1341
|
artikel
|
| 2 |
Air pollution—time to address the silent killer
|
The Lancet Respiratory Medicine,
|
|
|
9 |
11 |
p. 1203
|
artikel
|
| 3 |
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
|
Radicioni, Giorgia
|
|
|
9 |
11 |
p. 1241-1254
|
artikel
|
| 4 |
A sudden deterioration in idiopathic pulmonary fibrosis
|
Scallan, Ciaran J
|
|
|
9 |
11 |
p. 1342
|
artikel
|
| 5 |
COPD exacerbations: targeting IL-33 as a new therapy
|
Kim, Richard Y
|
|
|
9 |
11 |
p. 1213-1214
|
artikel
|
| 6 |
Correction to Lancet Respir Med 2021; 9: 1299–312
|
|
|
|
9 |
11 |
p. e106
|
artikel
|
| 7 |
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
|
Diver, Sarah
|
|
|
9 |
11 |
p. 1299-1312
|
artikel
|
| 8 |
European Respiratory Society International Congress 2021
|
Venkatesan, Priya
|
|
|
9 |
11 |
p. e107-e108
|
artikel
|
| 9 |
Every deep-drawn breath
|
O'Connor, Aine
|
|
|
9 |
11 |
p. 1218
|
artikel
|
| 10 |
Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19
|
Richardson, Christopher D
|
|
|
9 |
11 |
p. 1207-1209
|
artikel
|
| 11 |
How to avoid an epidemic of endotracheal tube occlusion
|
Lellouche, François
|
|
|
9 |
11 |
p. 1215-1216
|
artikel
|
| 12 |
Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial
|
Meiser, Andreas
|
|
|
9 |
11 |
p. 1231-1240
|
artikel
|
| 13 |
Inhaled trepostinil for severe fibrotic interstitial lung disease: grounds for cautious optimism?
|
Harari, Sergio
|
|
|
9 |
11 |
p. 1209-1211
|
artikel
|
| 14 |
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
|
Nathan, Steven D
|
|
|
9 |
11 |
p. 1266-1274
|
artikel
|
| 15 |
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
|
Tober-Lau, Pinkus
|
|
|
9 |
11 |
p. e104-e105
|
artikel
|
| 16 |
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management
|
McCarthy, Cormac
|
|
|
9 |
11 |
p. 1313-1327
|
artikel
|
| 17 |
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
|
Evans, Rachael A
|
|
|
9 |
11 |
p. 1275-1287
|
artikel
|
| 18 |
Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial
|
|
|
|
9 |
11 |
p. 1221-1230
|
artikel
|
| 19 |
Routine use of continuous positive airway pressure after major abdominal surgery
|
Hess, Dean R
|
|
|
9 |
11 |
p. 1204-1205
|
artikel
|
| 20 |
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
|
Rabe, Klaus F
|
|
|
9 |
11 |
p. 1288-1298
|
artikel
|
| 21 |
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
|
Hillus, David
|
|
|
9 |
11 |
p. 1255-1265
|
artikel
|
| 22 |
Sedation in critically ill patients: will the vaporiser replace the syringe?
|
Schultz, Marcus J
|
|
|
9 |
11 |
p. 1205-1207
|
artikel
|
| 23 |
Silicosis and the countertop industry
|
Burki, Talha Khan
|
|
|
9 |
11 |
p. 1217
|
artikel
|
| 24 |
Surviving COVID-19: a familiar road to recovery?
|
Denehy, Linda
|
|
|
9 |
11 |
p. 1211-1213
|
artikel
|
| 25 |
The importance of patient-reported outcomes and measures
|
Burki, Talha Khan
|
|
|
9 |
11 |
p. 1218-1220
|
artikel
|
| 26 |
The race between vaccination and evolution of COVID-19 variants
|
Burki, Talha Khan
|
|
|
9 |
11 |
p. e109
|
artikel
|
Tijdschrift beschrijving